Brief: AB Science To Present Latest Clinical Data On ALS At 2021 Symposium
02/09/2021 17:07
Sept 2 (Reuters) - AB Science SA ABS.PA :
* AB SCIENCE ANNOUNCED TODAY THAT LATEST CLINICAL DATA ON
LONG-TERM SURVIVAL ANALYSES IN ALS WILL BE PRESENTED AT THE 2021
SYMPOSIUM ON ALS/MND
Source text for Eikon: ID:nGNX1cJ0jf
Further company coverage: ABS.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on AB Science SA
See all newsBrief: AB Science Temporarily Halts Europe Clinical Trials Ahead Of Strategic Reorganization
Brief: AB Science Says FDA Granted Status Of Minor Use In Major Species For Masivet
Brief: AB Science Says Co Received Japanese Patent Protection To Use Masitinib In Progressive MS Until 2041
Brief: AB Science Phase 1 AML Study Of AB8939 Shows 100% Partial Response Rate
Brief: AB Science Receives Notice Of Allowance For European Patent Covering Masitinib Until 2040 In Treatment Of Sickle Cell Disease